baber/WOPTO huggingface dataset:
Patent PT-2160367-E (PT)
Title: Process for preparing a filler for asphalt or concrete starting from a slag material
Inventor: NGUYEN EVELYNE
IPC: C04B5/06
Filed: 2008-06-02
Abstract: The present invention relates to a process for preparing, starting from a slag material, a filler for construction materials which contain bitumen or a hydraulic binding agent. The slag used to prepare the filler contains gamma-dicalcium silicate. The process comprises the step of removing from the slag material a finer fraction formed by particles of a size between 0 and at least 0.75 mm so as to reduce the gamma-dicalcium silicate content of the slag material; and the step of finely milling at least a portion of the remaining coarser fraction of the slag to obtain the filler. The invention also relates to the obtained filler, to the use thereof for preparing construction materials and to concrete or mortar compositions and asphalt compositions containing the filler. By removing the finer fraction from the slag material, a filler is obtained which has a considerably lower water content so that it becomes suitable for use in asphalt or concrete or mortar compositions, in particular in self-compacting concrete compositions.
Patent PT-2256061-E (PT)
Title: Product with bioreabsorbent carrier materials and packaging
Inventor: BAECKER IWER
IPC: A61B19/02
Filed: 2009-05-30
Abstract: The product has a package comprising an adsorbent such as silica gels, and a mechanically stable base element (1) with cavities (2a) for receiving a bioresorbable carrier material such as silica gel fibers. A sealing film (3) closes an opening of the cavity. A bag (4) made of aluminum or aluminum laminated film completely surrounds and seals the base element with the sealing film. The base element comprises a metal foil made of aluminum or laminated aluminum foil. The cavities comprise a base plate (5). An independent claim is also included for a method for manufacturing a product.
Patent PT-699150-E (PT)
Inventor: LOHR ROBERT
IPC: B62D1/26
Filed: 1994-05-25
Abstract: PCT No. PCT/FR94/00612 Sec. 371 Date Jan. 29, 1996 Sec. 102(e) Date Jan. 29, 1996 PCT Filed May 25, 1994 PCT Pub. No. WO94/27854 PCT Pub. Date Dec. 8, 1994A unit for automatically guiding a vehicle along a rail comprising an arm (2) hingedly mounted, via a universal joint, to an end (3) of a chassis. The arm (2) includes, at a front end thereof, a mechanism for rolling (7, 8) along a rail (9) which comprises a pair of rollers (35, 36) mounted in a V-shaped configuration to encompass the rail (9) by lateral rolling engagement along each flank of the rollers. The unit is also provided with an arm raising mechanism, a mechanical coupling to the steering mechanism of the vehicle and various sensors. The invention is primarily applicable for the manufacture and use of urban public transport vehicles.
Patent PT-729373-E (PT)
Inventor: ENGDAHL HOLGER
IPC: B01D29/50
Filed: 1994-10-27
Abstract: PCT No. PCT/FI94/00485 Sec. 371 Date Jun. 1, 1995 Sec. 102(e) Date Jun. 1, 1995 PCT Filed Oct. 27, 1994 PCT Pub. No. WO95/12446 PCT Pub. Date May 11, 1995A cross-flow filtration apparatus is able to produce cleaner liquid, especially in the filtration of green liquor, then is typically possible. A housing contains a number of vertical filter elements each having a filter surface with first and second sides which are substantially free of filter cake. A higher gas pressure is provided on the first sides of the filter surfaces than the second sides, and filtered liquid passes through the filter surface from the first side to the second side. A first conduit withdraws filtrate from the second side of at least one of the surfaces, and a second conduit withdraws suspension liquid from adjacent the bottom of the filter elements and typically (though not necessarily) recirculates it. Suspension is introduced-such as in a tray with a perforated bottom mounted above the filter elements, and/or the nozzles-so that the suspension flows in a falling film down the first sides and in contact with them, so that filter cake does not form during operation. A sludge vessel is typically connected to the second conduit external of the housing, and an open dregs vessel distinct from the sludge vessel may be connected to a bottom portion of the housing.
Patent PT-754200-E (PT)
Inventor: CARLBLOM LELAND H
IPC: C08J7/04
Filed: 1995-02-07
Abstract: Polyepoxide-polyamine gas barrier coatings for use on packaging materials such as polymeric containers are provided with more stable low permeability at high humidity conditions by including high aromatic content in systems cured with a substantial excess of polyamine. The polyamine is an adduct of a polyamine having high aromatic content reacted with epichlorohydrin, certain polyepoxides, novolac epoxy resin, bisphenof F epoxy resin, or formaldehyde/phenol Mannich bases. The polyamine adduct is cured with polyepoxide which also may have aromatic content, with the exclusion of bisphenol A epoxy resins.
Patent PT-782441-E (PT)
Inventor: WILLIS DEAN
IPC: A61P29/00
Filed: 1995-09-22
Abstract: Control of inflammation is achieved by control of the level and/or activity of the enzyme heme-oxygenase (HO). A HO inducer is anti-inflammatory (figure 14) and used to treat inflammation, such as chronic inflammatory diseases. A HO inhibitor promotes inflammation and is used to treat immunosuppressed conditions. Alternative, or additional, control of heme-oxygenase activity is achieved by control of nitric oxide levels, elevated levels promoting inflammation.
Patent PT-1032680-E (PT)
Inventor: BASZCZYNSKI CHRISTOPHER L
IPC: C12N15/82
Filed: 1998-11-17
Abstract: Compositions and methods for introducing a DNA of interest into a genomic target site are provided. In particular, the methods and compositions involve the use of a combination of target sites for two site specific recombinases and expression of a chimeric recombinase with dual target site specificity. Thus, the compositions comprise novel site-specific recombinases with specificities to multiple target sites, and nucleotide sequences and expression cassettes encoding these recombinases or target sites. The methods involve transforming a eukaryotic cell having target sites for the novel recombinase with a DNA of interest that is flanked by corresponding target sites. Expression of the recombinase results in integration of the DNA of interest into the genome of the cell. The compositions and methods of the invention have use in the construction of stably transformed eukaryotic cells, and in particular, plant cells. The methods result in the efficient targeted genomic integration of DNA by site-specific recombination.
Patent PT-1022507-E (PT)
Inventor: HANS UNGER
IPC: H05K5/06
Filed: 1999-12-24
Abstract: The closure cover has a supporting body (3) connected to at least one sealing ring (5) on the side facing the boundary of the opening (1). The sealing ring is made in one piece with a membrane (7) of the same elastomeric material to accommodate volume changes in the sealed chamber (6) inside the housing. The supporting body, sealing ring and membrane form a pre-mounted unit. The membrane is covered by a lid (9) on the side remote from the sealed chamber that snap fits to the unit.
Patent PT-968715-E (PT)
Inventor: BUCKLAND GUY
IPC: A61K31/4523
Filed: 1999-06-04
Abstract: A method of treating atrial fibrillation in mammals using loratadine.
Patent PT-1045644-E (PT)
Inventor: ANDERSEN HENRIK
IPC: A23L27/30
Filed: 1999-01-05
Abstract: D-tagatose is used to synergize the effect of potent sweeteners. When combined with one or more potent sweeteners, it is able to effect improvements in sensory characteristics such as mouthfeel, flavor and aftertaste of a sweetened product.
Patent PT-1050176-E (PT)
Inventor: MIKA FORSSELL
IPC: H04W92/24
Filed: 1999-02-11
Abstract: A method of transmitting data in a packet radio network to a mobile station performing a routing area update. The packet radio network transmits data to the mobile station via a first support node. The mobile station sends a routing area update message to a second support node, which sends to the first support node a request for context data of the mobile station from the first support node. The first support node sends from its memory, end user data addressed to the mobile station to the second support node. It then waits for a predetermined period of time before sending the end user data to the second support node. The predetermined time may be fixed, depending preferably on the quality of service of the connection used by the mobile station. Alternatively the predetermined period of time expires when the second support note sends to the first support node a separate acknowledgement message indicating that the second support node has received the context data of the mobile station.
Patent IE-810224-L (IE)
Title: Anaesthetic gas scavenging devices
IPC: A61M16/00
Filed: 1981-02-06
Abstract: Compressible bag 11 which is manipulated by an anaesthetist to control the breathing of a paediatric patient to whom mask 32 is applied, is disposed within a collector dish 12 so that exhaled breath and excess anaesthetic gas can be aspirated away by way of a coupling tube 19 connected to an exhaust duct 26, thereby to avoid pollution of the atmosphere with anaesthetic gas. The dish 12 has a half lid 16 permitting access to the bag 11. <IMAGE>
[GB2070940A]
Patent IE-44621-L (IE)
Title: Dynamic test apparatus
IPC: G01N3/32
Filed: 1977-02-25
Abstract: An instrument for determining the complex mechanical response of samples incorporates two parallel sample arms each pivotally mounted at their central portion by flexure pivots of precisely known spring constants. The sample is mounted on one end of each. An electromechanical driver acts on the other end of one arm to maintain the arms and sample in mechanical oscillation about the pivots. A displacement transducer senses the mechanical motion. A feedback amplifier between the displacement transducer and the driver maintains the oscillation at a constant amplitude and at a resonant frequency determined primarily by the sample. With this arrangement the driver and displacement sensor are removed from the sample and its usual thermal chamber. This improves the stability of the instrument. At the same time the arms are dynamically balanced about the pivots and hence are relatively insensitive to vibrational upset.
[US4034602A]
Patent IE-830696-L (IE)
Title: N-heterocyclylpolymethyleneimines
IPC: A61K31/495
Filed: 1983-03-29
Abstract: Polymethylene-imines of the formula:   <IMAGE>   in which: A is a hydrocarbon radical from C3 to C5 in a straight or branched chain possibly containing one or two double bonds and possibly substituted by one or more hydroxy radicals; X is CH or nitrogen; n is zero, one or two; Y is oxygen or N-R1 in which R1 is hydrogen, alkyl from C1 to C5, alkenyl from C2 to C5, cycloalkyl or cycloalkenyl from C3 to C7, or acetyl; R is hydrogen, alkyl from C1 to C5, cycloalkyl from C5 to C7 or phenyl optionally substituted by one or more fluorine or chlorine; and B is hydrogen, alkyl from C1 to C5, alkenyl from C2 to C5, or phenyl, naphthyl, benzofuranyl, benzothienyl, benzodioxolyl, benzodioxanyl, benzodioxinyl,  DELTA 3-chromanyl, thiochromenyl or chromanyl, each optionally substituted by fluorine, chlorine, alkyl or alkoxy from C1 to C5; or a radical of the formula:    <IMAGE>   in which: R2, R3 and R4 which may be the same or different, each represent hydrogen, or phenyl optionally substituted by fluorine or chlorine. These compounds and physiologically tolerable acid addition salts thereof may be used as medicines especially in the treatment of all kinds of tissular hypoxia.
Patent IE-37637-L (IE)
Title: Coated antibiotic microcapsules
IPC: B01J13/04
Filed: 1973-05-15
Abstract: 1403584 Encapsulated antibiotics BEECHAM GROUP LTD 16 May 1973 [19 May 1972] 23576/72 Heading A5B A powder useful in the formulation of pharmaceutical preparations consists essentially of "microcapsules" having an average diameter of 100Á to 300u, at least 90% of the microcapsules having diameters in the range 75u to 450Á and which comprises 98% to 99.9% of a #-lactam antibiotic coated by 0.17 to 2% of polyvinylpyrrolidone. The term "microcapsule" means a particle composed of an outer, generally porous shell of PVP as coating agent with an inner core of fine particles. They may be made by spray-drying a slurry of antibiotic in a solution of PVP in a suitable solvent. Many conventional solid and liquid formulations comprising the microcapsules are mentioned. Specified antibiotics include; ampicillin, amoxicillin, isoxazolylpenicillin, salts and esters thereof and esters of ampicillin and carbenicillin.
[GB1403584A]
Patent FI-822399-L (FI)
Inventor: BETHGE HORST
IPC: C07C215/30
Filed: 1982-07-06
Abstract: There is described the resolution of the racemate (1RS,2SR)-2-amino-1-phenyl-propan-1-ol. It is carried out by means of the optical isomers of S-(carboxymethyl)-cysteine.
Patent FI-824254-L (FI)
Inventor: RUDOLPH GERD
IPC: A24B3/18
Filed: 1982-12-10
Abstract: The impairment of the taste of smoke, observed in processes for improving the filling capacity of tobacco by expansion of the tobacco with a vaporizable expanding agent, can be avoided if an anti-oxidant, in particular ascorbic acid, is added to the tobacco before the expansion. In addition, anti-oxidant synergists can also be added.
Patent FI-851843-L (FI)
Inventor: FOCK KURT
IPC: C08K5/07
Filed: 1985-05-09
Abstract: Reduction in the adhesion to glass of thermoplastic, plasticized polyvinylbutyral molding compositions, in particular sheeting, by the addition of a metal salt and/or metal chelate of an enolizable  beta -diketone, or mixtures of these compounds, as an non-stick agent, preferably in amounts of 0.003 to 0.3% by weight, relative to the plasticized polyvinylbutyral. It is preferable to employ the non-stick agent in the form of a solution in the plasticizer. The use of the sheeting having an adhesion to glass reduced in accordance with the invention as a laminating layer for the production of glass laminates.
Patent FI-853431-L (FI)
Inventor: SCOTT RICHARD A
IPC: A61K31/07
Filed: 1985-09-09
Abstract: An excipient for the application of active pharmaceutical ingredients to human skin in such a way that the biological activity, subcutaneous adsorption and efficacy of the active ingredient are considerably improved. The excipient contains volatile silicone, a fatty alcohol with 12-22 carbon atoms, a preselected active ingredient and protective substances or emulsifiers of a desired type.
Patent IE-821464-L (IE)
Title: Tape cassettes
IPC: G11B23/08
Filed: 1982-06-21
Abstract: PURPOSE: To protect a tape which extends along the opening part in one side surface of a tape cassette, by sandwiching before and behind side of the tape between a front and an internal cover, capable of opening and closing freely and then closing the covers. CONSTITUTION: A front cover 20 is pushed up with a loaded cassette and opened against the elasticity of a torsion bar 26. The guide pin 41 of an internal cover 37 is guided to a groove 44, and the internal cover 37 is opened at the lower part of the front cover 20. The guide pin 41, after passing the center part 45 of the guide groove 44, rotates clockwise and when front cover 20 is opened completely, the internal cover 37 is horizontal and an upper cover 29 slides to behind the top surface wall of an upper half 2[JP57210489A]
Patent IE-35154-L (IE)
Title: Migrane relief
IPC: A61K31/495
Filed: 1970-12-04
Abstract: 1311286 Migraine treatment H WILD 4 Dec 1970 [5 Dec 1969] 59643/69 Heading A5B Pharmaceutical compositions for the treatment and prevention of migraine comprise (a) a 1, 4-disubstituted piperazine having the general formula: wherein X is H, Cl or Br and R<SP>1</SP> and R<SP>2</SP> each represent H or a C 1-6 alkyl, at least one of R<SP>1</SP> and R<SP>2</SP> being an alkyl group, or a salt thereof e.g. salts with hydrochloric, phosphoric, lactic, maleic, fumaric and tartaric acids, and (b) N-acetyl-p-aminophenol (paracetamol), pethoxyacetanilide (phenacetin), salicylamide and/or acetylsalicylic acid, the weight ratio of (a) to (b) being from 1:20 to 1:200. A preferred composition comprises 1-p-chlorobenzhydryl-4- p-(tertiary butyl) benzyl piperazine (buclizine) and paracetamol. The compositions may be administered orally or rectally in the form of tablets, capsules, suspensions, syrups, and suppositories. Migraine may be prevented by the simultaneous administration of dosage units comprising appropriate quantities of (a) and (b) and the invention also relates to a pharmaceutical package comprising separate dosage unit forms containing (a) and (b). The composition may also be formulated as a dosage form divided into separate portions by an internal division which is easily ruptured or dissolved by body fluid, compounds (a) and (b) being confined to different compartments. The compositions may also contain additional analgesics such as codeine or dextropropoxyphene.
[GB1311286A]
Patent IE-901688-L (IE)
Title: Sprayable composition
IPC: C09K17/52
Filed: 1990-05-09
Abstract: A sprayable composition and a method of protecting material with the composition is disclosed. The composition comprises a polymer such as hydroxyethyl cellulose, clay, and water to provide a cover layer which, after spraying, is tough, flexible and water-repellent. Other materials such as shredded paper and gypsum can be used in the cover layer. The composition is effective as a cover layer over material such as soil, refuse at a dump site, or grain in a stockpile.
Patent IE-851946-L (IE)
Title: Manufacturing plaster panels
IPC: C04B24/38
Filed: 1985-08-06
Abstract: 1. Process for the manufacture of gypsum boards, characterized by the fact there is used as a bonding agent protective colloid, an amount of amylaceous material representing from 0.2 to 2 % by weight with respect to the weight of plaster employed, said amylaceous material comprising, on the one hand, a proportion of at least 30 %, preferably at least 45 % by weight of particles of native wheat starch of dimension less than 10.7 mu m and, on the other hand, a proportion of at the most 20 % by weight of particles of native wheat starch of dimension greater than 35 mu m, the presence of these two granulometric fractions being determined by a method A of analysis.
Patent IE-45715-L (IE)
Title: Preparing a 9-[piperazinyl¹propylidene]-thioxanthene-2-sulfonamide
IPC: A61K31/38
Filed: 1977-10-19
Abstract: Trans-N,N-dimethyl-9-[3-(4-methyl-1-piperazinyl)propylidene]-thioxanth ene-2-sulfonamide is isomerized to the cis-isomer by contacting the trans-isomer with strong base in a polar organic solvent. By using an organic solvent in which the solubility of the cis-isomer is substantially less than that of the trans-isomer, the cis-isomer can be selectively precipitated from said solvent, thereby favoring additional isomerization to the cis-isomer in the supernatant, and separated.
[US4107430A]
Patent IE-802401-L (IE)
Title: Manufacturing semiconductor devices
IPC: H01L21/8222
Filed: 1980-11-19
Abstract: A structure and method for manufacturing semiconductor devices by the master slice method, in which various kinds of semiconductor devices are manufactured through utilization of a common master pattern and a plurality of different kinds of selective wiring patterns. A number of bipolar transistors each having plural emitter regions, is formed in a predetermined region, or portion, of a semiconductor substrate by employing a common master pattern, and the plural emitter regions of the respective bipolar transistors are selectively connected by the associated wiring patterns of each thereof to form corresponding bipolar transistors of different, predetermined D.C. characteristics. When manufacturing many different kinds of semiconductor devices by the master slice method, the area which would be wasted on the semiconductor substrate by prior art techniques is greatly reduced, thus providing for enhanced area efficiency.
[US4388755A]
Patent IE-46215-L (IE)
Title: Gamma-globulins, immune nucleic acids and immune dialysates.
IPC: C12N5/071
Filed: 1977-12-14
Abstract: Gamma-globulins and immune nucleic acids, both specific to a given antigen, are produced by culturing in vitro an inducible cell line in the presence of specific immune nucleic acids or specific immune dialysates obtained either from human or animal donor lymphoid cells sensitized to said specific antigen or from cells of a previously induced cell line sensitized to said specific antigen, or in the presence of the liquid phase of a culture of a previously induced cell line sensitized to said specific antigen; and extracting gamma-globulins from the liquid phase of the thus induced cell culture and/or extracting the immune nucleic acids from the cells so cultured. Specific immune dialysates may also be produced by a similar process.
[US4224404A]
Patent IE-43206-L (IE)
Title: Separating crystallizable materials from a multi-component¹system
IPC: B01D9/00
Filed: 1975-12-05
Abstract: 1507034 Crystallisation process DEJ INTERNATIONAL RESEARCH CO BV 26 Nov 1975 [6 Dec 1974] 52900/74 Heading BIG A process for separating crystallisable material out of a multi - component liquid system comprises the following steps performed in sequence latchwise: (a) confining a batch of liquid in a heat exchanger, (b) applying cooling to the heat exchanger to crystallise at least part of the crystallisable material and create a substantially coherent matrix of crystals, (c) removing the material formed in step (b) from the heat exchanger, (d) breaking up the material from step (c) into a predetermined size and (e) separating crystallised material from the remainder of the multi - component system. Suitable aparatus, as shown in Fig. 1, for the freeze concentration of e.g. aqueous systems such as coffee extract and fruit juices, comprises a storage vessel (1), a number of shell and tube heat exchangers (3-12) mounted in parallel and connected to a central feed line, below the heat exchangers are an equal number of grinding means for breaking up the columns of ice and concentrate and simultaneously mixing the broken ice with recirculated concentrate and a washing column (13) for separating ice and concentrate. The process is carried out so that at the end of each freeze cycle the pump (2) pumps feed solution into the heat exchanger and so forces the columns of ice crystals and concentrate which have formed in the heat exchanger out of the exchanger, the columns of ice having first been released from the tube walls by briefly applying heat. A new freezing cycle starts when only a small frozen plug (28) remains in each tube (27). The frozen columns are broken up upon leaving the tubes by the knives (30) driven by a motor (33). The mixture of ice and concentrates enters the mixing vessel (32) at regular intervals and is transformed into a slurry for processing by the separating apparatus i.e. a washing column (13).
[GB1507034A]
Patent IE-832708-L (IE)
Title: 6ó-methyl-corticoids.
IPC: C07J7/00
Filed: 1983-11-21
Abstract: 6 alpha -Methyl corticoids of formula I    <IMAGE>  (I)  wherein   is a single bond or a double bond, R is acyloxy of up to 8 carbon atoms, and X is chlorine, hydroxy, or acyloxy of up to 8 carbon atoms, are pharamacologically effective substances.